Showing results (1691-1700 of 3,307) with videos related to
Sort By:
Pageof 331
Metabolic Brain Disease|January 4, 2019
Effect of orange juice and tryptamine on the behavior and c-fos expression of Wistar ratsAlma Vázquez-Luna, Fabio García-García, Diana I Caudillo Contreras, et al.Metabolic Brain Disease|January 4, 2019
Enriched environment modulates behavior, myelination and augments molecules governing the plasticity in the forebrain region of rats exposed to chronic immobilization stressGangadharan Thamizhoviya, Arambakkam Janardhanam VanisreeMetabolic Brain Disease|June 28, 2007
Effects of development and dopamine depletion on striatal NMDA receptor-mediated calcium uptakeThabelo Khoboko, Vivienne A RussellMetabolic Brain Disease|July 26, 2006
Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptorsBrian H Harvey, Renché Retief, Ané Korff, et al.Metabolic Brain Disease|July 26, 2006
Analysis of viral and genetic factors in South African patients with multiple sclerosisJ Nico P de Villiers, Florette K Treurnicht, Louise Warnich, et al.Metabolic Brain Disease|June 15, 2006
Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatumAlexandra I Zugno, Emilene B S Scherer, Patrícia F Schuck, et al.Metabolic Brain Disease|May 27, 2006
Iron and the folate-vitamin B12-methylation pathway in multiple sclerosisS J van Rensburg, M J Kotze, D Hon, et al.Metabolic Brain Disease|July 20, 2006
A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorderJ M Warwick, P Carey, G Van der Linden, et al.Metabolic Brain Disease|February 14, 2007
Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortexAndré Wajner, Cristiane Bürger, Carlos Severo Dutra-Filho, et al.Metabolic Brain Disease|June 1, 1991
Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathyG Therrien, R F ButterworthPageof 331